newsfilter
← Latest News
PR Newswire·

MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

NEW YORK, Sept. 23, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that Dr. Matthias Liechti presented